JP2021512889A5 - - Google Patents
Info
- Publication number
- JP2021512889A5 JP2021512889A5 JP2020542437A JP2020542437A JP2021512889A5 JP 2021512889 A5 JP2021512889 A5 JP 2021512889A5 JP 2020542437 A JP2020542437 A JP 2020542437A JP 2020542437 A JP2020542437 A JP 2020542437A JP 2021512889 A5 JP2021512889 A5 JP 2021512889A5
- Authority
- JP
- Japan
- Prior art keywords
- pyridine
- benzodiazole
- fluoro
- substituted
- unsubstituted
- Prior art date
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629377P | 2018-02-12 | 2018-02-12 | |
| US62/629,377 | 2018-02-12 | ||
| US201862673042P | 2018-05-17 | 2018-05-17 | |
| US62/673,042 | 2018-05-17 | ||
| US201862724421P | 2018-08-29 | 2018-08-29 | |
| US62/724,421 | 2018-08-29 | ||
| PCT/US2019/017529 WO2019157458A1 (en) | 2018-02-12 | 2019-02-11 | Somatostatin modulators and uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021512889A JP2021512889A (ja) | 2021-05-20 |
| JP2021512889A5 true JP2021512889A5 (https=) | 2022-02-21 |
| JPWO2019157458A5 JPWO2019157458A5 (https=) | 2022-02-21 |
| JP7365347B2 JP7365347B2 (ja) | 2023-10-19 |
Family
ID=67548490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542437A Active JP7365347B2 (ja) | 2018-02-12 | 2019-02-11 | ソマトスタチンモジュレーターおよびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11608335B2 (https=) |
| EP (1) | EP3752498B1 (https=) |
| JP (1) | JP7365347B2 (https=) |
| MA (1) | MA51840A (https=) |
| WO (1) | WO2019157458A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018170284A1 (en) | 2017-03-16 | 2018-09-20 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| EP3752498B1 (en) | 2018-02-12 | 2023-06-28 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| AR116424A1 (es) | 2018-09-18 | 2021-05-05 | Crinetics Pharmaceuticals Inc | Moduladores de la somatostatina y usos de los mismos |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
| EP4294797A1 (en) | 2021-02-17 | 2023-12-27 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of a somatostatin modulator |
| CA3207382A1 (en) * | 2021-02-17 | 2022-08-25 | Christine FERRARA-COOK | Somatostatin receptor type 5 agonist for the treatment of hyperinsulinism |
| AU2023366475A1 (en) * | 2022-10-28 | 2025-05-29 | Exelixis, Inc. | Somatostatin receptor 2 agonists and uses thereof |
| JP2026500913A (ja) | 2022-12-13 | 2026-01-09 | クリネティックス ファーマシューティカルズ，インク． | ソマトスタチンサブタイプ－２受容体（ｓｓｔ２ｒ）標的化治療薬及びその使用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6127343A (en) | 1996-05-14 | 2000-10-03 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
| US6025372A (en) | 1997-04-04 | 2000-02-15 | Merck & Co., Inc. | Somatostatin agonists |
| FR2802206B1 (fr) | 1999-12-14 | 2005-04-22 | Sod Conseils Rech Applic | Derives de 4-aminopiperidine et leur utilisation en tant que medicament |
| US20060281764A1 (en) | 2005-06-10 | 2006-12-14 | Gaul Michael D | Aminopyrimidines as kinase modulators |
| CA2644929A1 (en) * | 2006-03-13 | 2008-05-02 | Merck & Co., Inc. | Somatostatin agonists |
| EP2054385A2 (en) | 2006-08-15 | 2009-05-06 | F. Hoffmann-Roche AG | Phenyl, pyridine and quinoline derivatives |
| EP2211619A1 (en) | 2007-10-18 | 2010-08-04 | Merck Sharp & Dohme Corp. | Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| CA2729220A1 (en) | 2008-06-25 | 2009-12-30 | Envivo Pharmaceuticals, Inc. | Di-substituted phenyl compounds |
| GB0818241D0 (en) | 2008-10-06 | 2008-11-12 | Cancer Res Technology | Compounds and their use |
| CA2772194A1 (en) | 2009-09-01 | 2011-03-10 | Pfizer Inc. | Benzimidazole derivatives |
| CA2799414A1 (en) | 2010-05-18 | 2011-11-24 | Merck Sharp & Dohme Corp. | Spiro isoxazoline compounds as sstr5 antagonists |
| GB201008290D0 (en) | 2010-05-18 | 2010-06-30 | Syngenta Ltd | Chemical compounds |
| WO2014007228A1 (ja) * | 2012-07-03 | 2014-01-09 | 小野薬品工業株式会社 | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 |
| AU2014325078B2 (en) * | 2013-09-30 | 2018-10-25 | Ono Pharmaceutical Co., Ltd. | Compound having agonistic activity to somatostatin receptor and medicinal use thereof |
| CN105579524B (zh) | 2013-10-02 | 2018-05-04 | 株式会社可乐丽 | 树脂组合物、多层片、包装材料和容器 |
| HRP20221279T1 (hr) | 2016-07-14 | 2022-12-23 | Crinetics Pharmaceuticals, Inc. | Modulatori somatostatina i njihove uporabe |
| CN110300749A (zh) | 2017-02-08 | 2019-10-01 | 小野药品工业株式会社 | 具有生长抑素受体激动活性的化合物及其医药用途 |
| WO2018170284A1 (en) * | 2017-03-16 | 2018-09-20 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| US11028068B2 (en) | 2017-07-25 | 2021-06-08 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| EP3752498B1 (en) | 2018-02-12 | 2023-06-28 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
| AR116424A1 (es) | 2018-09-18 | 2021-05-05 | Crinetics Pharmaceuticals Inc | Moduladores de la somatostatina y usos de los mismos |
| TWI841768B (zh) | 2019-08-14 | 2024-05-11 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
-
2019
- 2019-02-11 EP EP19751144.7A patent/EP3752498B1/en active Active
- 2019-02-11 US US16/968,533 patent/US11608335B2/en active Active
- 2019-02-11 WO PCT/US2019/017529 patent/WO2019157458A1/en not_active Ceased
- 2019-02-11 MA MA051840A patent/MA51840A/fr unknown
- 2019-02-11 JP JP2020542437A patent/JP7365347B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512889A5 (https=) | ||
| JP2019518036A5 (https=) | ||
| AU2007333992B2 (en) | Compounds and compositions as inhibitors of Cannabinoid Receptor 1 activity | |
| RU2317291C2 (ru) | Производные пиримидина в качестве модуляторов рецептора инсулинподобного фактора роста 1 (igf-1), фармацевтическая композиция, способы получения (варианты) и применение | |
| JP3930560B2 (ja) | 炎症の処置のための１，２−置換イミダゾリル化合物 | |
| RU2019132212A (ru) | Селективные ингибиторы hdac6 | |
| JP2018535999A5 (https=) | ||
| JP2007531752A5 (https=) | ||
| JP2018530591A5 (https=) | ||
| RU2016141646A (ru) | Ингибиторы trka киназы, основанные на них композиции и способы | |
| JP2019537571A5 (https=) | ||
| RU2012116207A (ru) | Производные индола в качестве модуляторов crac | |
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| JP2015528022A5 (https=) | ||
| HRP20170506T1 (hr) | Dihidropiridon p1 kao inhibitori xia faktora | |
| JP2014511869A5 (https=) | ||
| JP2019537594A5 (https=) | ||
| JP2004531473A5 (https=) | ||
| RU2004112191A (ru) | Лактамсодержащие соединения и их производные в качестве ингибиторов фактора ха | |
| CA2714058A1 (en) | 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease | |
| RU2003115612A (ru) | Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы | |
| JP2005526815A5 (https=) | ||
| JP2020532589A5 (https=) | ||
| ES2197983T3 (es) | Imidazoles sustituidos con heterociclo para el tratamiento de la inflamacion. | |
| JP2020508300A5 (https=) |